Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000082541 | SCV000114583 | benign | not specified | 2015-10-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000082541 | SCV000315791 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000318202 | SCV000464103 | benign | Autosomal recessive polycystic kidney disease | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Genome Diagnostics Laboratory, |
RCV000318202 | SCV000743916 | benign | Autosomal recessive polycystic kidney disease | 2017-01-17 | criteria provided, single submitter | clinical testing | |
SIB Swiss Institute of Bioinformatics | RCV000318202 | SCV000803543 | benign | Autosomal recessive polycystic kidney disease | 2018-05-31 | criteria provided, single submitter | curation | This variant is interpreted as a Benign - Stand Alone, for Polycystic kidney disease 4 with or without polycystic liver disease, in Autosomal Recessive manner. The following ACMG Tag(s) were applied: BA1 => Allele frequency is >5% in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. |
Invitae | RCV000318202 | SCV001000534 | benign | Autosomal recessive polycystic kidney disease | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Pars Genome Lab | RCV001530437 | SCV001745265 | benign | Polycystic kidney disease 4 | 2021-06-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001705798 | SCV001885692 | benign | not provided | 2018-07-09 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25701400) |
Department of Pathology and Laboratory Medicine, |
RCV001291849 | SCV000592889 | benign | Polycystic kidney disease | no assertion criteria provided | clinical testing | The c.2489A>G, p.Asn830Ser variant was identified in 6.78% of 8237 control alleles in the Exome Aggregation Consortium (March 14, 2016). According to ACMG guidelines for variant classification based on allele frequency, category BA1, this variant is considered benign and has not been further reviewed (Richards 2015). | |
Diagnostic Laboratory, |
RCV000318202 | SCV000734508 | benign | Autosomal recessive polycystic kidney disease | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000318202 | SCV002081028 | benign | Autosomal recessive polycystic kidney disease | 2017-05-11 | no assertion criteria provided | clinical testing |